Innate Pharma
IPHA
#8394
Rank
NZ$0.29 B
Marketcap
$3.50
Share price
-0.25%
Change (1 day)
-17.32%
Change (1 year)

Operating Margin for Innate Pharma (IPHA)

Operating Margin at the end of 2023: -14.59%

According to Innate Pharma 's latest financial reports and stock price the company's current Operating Margin is -14.58%. At the end of 2023 the company had an Operating Margin of -14.59%.

Operating Margin history for Innate Pharma from 2005 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2023-14.59%-87.53%
2022-116.93%-68.86%
2021-375.54%25338.48%
2020-1.48%-112.87%
201911.47%237.09%
20183.40%-102.31%
2017-147.15%-738.58%
201623.04%-161.53%
2015-37.45%-98.27%
2014-2,166.15%9239.47%
2013-23.19%-24.76%
2012-30.83%-67.08%
2011-93.64%-70.38%
2010-316.16%66.79%
2009-189.55%106.52%
2008-91.78%47.07%
2007-62.41%-12.44%
2006-71.28%-71.58%
2005-250.78%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.